A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

por Bullard, D. E., Thomas, D. G., Darling, J. L., Wikstrand, C. J., Diengdoh, J. V., Barnard, R. O., Bodmer, J. G., Bigner, D. D.
Publicado 1985